Bibliografía
1. Ranjbar R, Behzadi P, Farshad S. Advances in diagnosis and treatment of Helicobacter pylori infection. Acta Microbiol Immunol Hung 2017:1-20. doi: 10.1556/030.64.2017.008.
2. Graham DY. History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World J Gastroenterol 2014; 20(18):5191-5204.
3. Ruggiero P. Helicobacter pylori and inflammation. Curr Pharm Des 2010; 16(38):4225-36.
4. Porras C, Nodora J, Sexton R, et al. Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701). Cancer Causes Control 2013; 24(2):209-15.
5. Schistosomes, liver flukes and Helicobacter pylori. IARC Monographs on the evaluation of Carcinogenic Risks to Humans 1994; 61: 1-241.
6. Conteduca V, Sansonno D, Lauletta G, et al. H. pylori infection and gastric cancer: State of the art (review). Int J Oncol 2013; 42:5-18.
7. Roesler BM, Rabelo-Gonçalves EM, Zeitune JM. Virulence Factors of Helicobacter pylori: A Review. Clin Med Insights Gastroenterol 2014; 7: 9–17.
8. Trujillo E, Martínez T, Bravo MM. Genotyping of Helicobacter pylori virulence factors vacA and cagA in individuals from two regions in Colombia with opposing risk for gastric cancer. Biomedica 2014; 34(4):567-73.
9. El Khadir M, Alaoui Boukhris S, Benajah DA, et al. VacA and CagA Status as Biomarker of Two Opposite End Outcomes of Helicobacter pylori Infection (Gastric Cancer and Duodenal Ulcer) in a Moroccan Population. PLoS One 2017; 12(1):e0170616. doi: 10.1371/journal.pone.0170616.
10. Dabiri H, Jafari F, Baghaei K, et al. Prevalence of Helicobacter pylori vacA, cagA, cagE, oipA, iceA, babA2 and babB genotypes in Iranian dyspeptic patients. Microb Pathog 2017; 105:226-230. doi: 10.1016/j.micpath.2017.02.018.
11. Ford AC, Forman D, Hunt RH, et al. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ 2014; 348:g3174. doi: 10.1136/bmj.g3174.
12. Milosavljević T, Kostić-Milosavljević M, Krstić M, et al. Epidemiological trends in stomach-related diseases. Dig Dis 2014; 32(3):213-6.
13. Raymond J, Thiberge JM, Dauga C. Diagnosis of Helicobacter pylori recurrence: relapse or reinfection? Usefulness of molecular tools. Scand J Gastroenterol 2016; 51(6):672-8. doi: 10.3109/00365521.2015.1132338.
14. Kim SY, Hyun JJ, Jung SW, et al. Helicobacter pylori Recurrence after First- and Second-Line Eradication Therapy in Korea: The Problem of Recrudescence or Reinfection. Helicobacter 2014; 19(3):202-6.
15. Niv Y. H pylori recurrence after successful eradication. World J Gastroenterol 2008; 14(10):1477-8.
16. Gisbert JP. The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review. Am J Gastroenterol 2005; 100(9):2083.99.
17. Parsonnet J. What is the Helicobacter pylori global reinfection rate? Can J Gastroenterol 2003 ;17 Suppl B:46B-48B.
18. Gómez Rodríguez BJ, Rojas Feria M, García Montes MJ, et al. Incidence and factors influencing on Helicobacter pylori infection recurrence. Rev Esp Enferm Dig 2004; 96(9):620-3; 424-7.
19. Novoa Reyes I, Caravedo Martínez M, Huerta-Mercado Tenorio J, et al. Recurrence rate of Helicobacter pylori infection two years after successful eradication in Peruvian patients presenting with postprandial distress syndrome. Rev Gastroenterol Peru 2014; 34(1):15-21.
20. Abdo-Francis JM, Uscanga-Domínguez LF, Sobrino-Cossio S, et al. Tercer consenso mexicano de Helicobacter pylori. Rev Gastroenterol Mex 2007; 72(3):321-38.
21. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20 (10): 1161-81.
22. Sánchez-Cuén JA, Canizalez-Román VA, León-Sicairos NM, et al. Concordance among invasive diagnostic procedures for Helicobacter pylori infection in adults. Salud Publica Mex 2015; 57(4):352-7.
23. Shahamat M, Alavi M, Watts J, et al. Development of two PCR-based techniques for detecting helical and coccoid forms of Helicobacter pylori. J Clin Microbiol 2004; 42(8):3613-9.
24. Atherton JC, Cao P, Peek RM, et al. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270(30):17771-7.
25. Yamaoka Y, Kodama T, Kita M, et al. Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter 1998; 3(4):241-53.
26. Rudi J, Rudy A, Maiwald M, Kuck D, Sieg A, Stremmel W. Direct determination of Helicobacter pylori vacA genotypes and cagA gene in gastric biopsies and relationship to gastrointestinal diseases. Am J gastroenterol 1999; 94(6):1525-31.
27. Rudi J, Kolb C, Maiwald M, et al. Diversity of Helicobacter pylori vacA and cagA Genes and Relationship to VacA and CagA Protein Expression, Cytotoxin Production, and Associated Diseases. J Clin Microbiol 1998; 36(4):944-8.
28. Lee YC, Lin JT. Screening and Treating Helicobacter pylori Infection for Gastric Cancer Prevention on the Population Level. J Gastroenterol Hepatol 2017. doi: 10.1111/jgh.13726.
29. Sánchez Cuén JA, Irineo Cabrales AB, Bernal Magaña G et al. Regresión de la metaplasia intestinal gástrica tras la erradicación de la infección por Helicobacter pylori en un hospital de México. Rev Esp Enferm Dig 2016; 108(12):770-775. doi: 10.17235/reed.2016.4194/2016
30. Sánchez Ceballos F, Taxonera Samsó C, García Alonso C, et al. Prevalence of Helicobacter pylori infection in the healthy population of Madrid (Spain). Rev Esp Enferm Dig 2007; 99(9):497-501.
31. Take S, Mizuno M, Ishiki K, et al. Reinfection rate of Helicobacter pylori after eradication treatment: a long-term prospective study in Japan. J Gastroenterol 2012; 47(6):641-6.
32. Zhou LY, Song ZQ, Xue Y, et al. Recurrence of Helicobacter pylori infection and the affecting factors: a follow-up study. J Dig Dis 2017; 18(1): 47-55. doi: 10.1111/1751-2980.12440.
33. Hirayama Y, Kawai T, Otaki J,et al. Prevalence of Helicobacter pylori infection with healthy subjects in Japan. J Gastroenterol Hepatol 2014; 29 Suppl 4:16-9. doi: 10.1111/jgh.12795.
34. Yu X, Yang X, Yang T, et al. Decreasing prevalence of Helicobacter pylori according to birth cohorts in urban China. Turk J Gastroenterol 2017; 28(2): 94-97. doi: 10.5152/tjg.2017.16557.
35. Kim SY, Hyun JJ, Jung SW, et al. Helicobacter pylori Recurrence after First- and Second-Line Eradication Therapy in Korea: The Problem of Recrudescence or Reinfection. Helicobacter 2014; 19(3):202-6.
36. Lim SH, Kwon JW, Kim N et al. Prevalence and risk factors of Helicobacter pylori infection in Korea: Nationwide multicenter study over 13 years. BMC Gastroenterol 2013; 13: 104 DOI: 10.1186/1471-230X-13-104.
37. Morgan DR, Torres J, Sexton R, et al. Risk of recurrent Helicobacter pylori infection 1 year after after initial eradication therapy in 7 Latin American communities. JAMA 2013; 309(6):578-86.
38. Sivapalasingam S, Rajasingham A, Macy JT, et al. Recurrence of Helicobacter pylori Infection in Bolivian Children and Adults After a Population-Based "Screen and Treat" Strategy. Helicobacter 2014; 19 (5): 343-348. doi: 10.1111/hel.12137.
39. Ortega JP, Espino A, Calvo B A, et al. Helicobacter pylori infection in symptomatic patients with benign gastroduodenal diseases. Analysis of 5.664 cases. Rev Med Chil 2010; 138(5):529-35. doi: /S0034-98872010000500001.
40. Meunier O, Walter P, Chamouard P, et al. Isolation of Helicobacter pylori: necessity of control of transport conditions. Pathol Biol (Paris) 1997; 45 (1): 82–85.
41. Martínez A, González C, Kawaguchi F, et al. Helicobacter pylori: cagA analysis and vacA genotyping in Chile. Detection of a s2/m1 strain. Rev Med Chil 2001; 129(10):1147-53.
42. Sugimoto M, Yamaoka Y. Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy. Arch Immunol Ther Exp (Warsz) 2009; 57:45-46.
43. Silva R, Casanova G, Albarracín Z, et al. Prueba del aliento y hallazgos histopatológicos asociados a la infección por Helicobacter pylori. Gen 2012; 66(2): 93-99.